PMID- 29403476 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20191120 IS - 1664-3224 (Print) IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 8 DP - 2017 TI - Contribution of IL-1RI Signaling to Protection against Cryptococcus neoformans 52D in a Mouse Model of Infection. PG - 1987 LID - 10.3389/fimmu.2017.01987 [doi] LID - 1987 AB - Interleukin-1 alpha (IL-1alpha) and interleukin-1 beta (IL-1beta) are pro-inflammatory cytokines that are induced after Cryptococcus neoformans infection and activate the interleukin-1 receptor type I (IL-1RI). To establish the role of IL-1RI signaling in protection against cryptococcal infection, we analyzed wild-type (WT) and IL-1RI-deficient (IL-1RI(-/-)) mice on the BALB/c background. IL-1RI(-/-) mice had significantly reduced survival compared to WT mice after intratracheal challenge with C. neoformans 52D. Microbiological analysis showed a significant increase in the lung and brain fungal burden of IL-1RI(-/-) compared to WT mice beginning at weeks 1 and 4 postinfection, respectively. Histopathology showed that IL-1RI(-/-) mice exhibit greater airway epithelial mucus secretion and prominent eosinophilic crystals that were absent in WT mice. Susceptibility of IL-1RI(-/-) mice was associated with significant induction of a Th2-biased immune response characterized by pulmonary eosinophilia, M2 macrophage polarization, and recruitment of CD4(+) IL-13(+) T cells. Expression of pro-inflammatory [IL-1alpha, IL-1beta, TNFalpha, and monocyte chemoattractant protein 1 (MCP-1)], Th1-associated (IFNgamma), and Th17-associated (IL-17A) cytokines was significantly reduced in IL-1RI(-/-) lungs compared to WT. WT mice also had higher expression of KC/CXCL1 and sustained neutrophil recruitment to the lung; however, antibody-mediated depletion of these cells showed that they were dispensable for lung fungal clearance. In conclusion, our data indicate that IL-1RI signaling is required to activate a complex series of innate and adaptive immune responses that collectively enhance host defense and survival after C. neoformans 52D infection in BALB/c mice. FAU - Shourian, Mitra AU - Shourian M AD - Division of Experimental Medicine, McGill University, Montreal, QC, Canada. AD - Meakins-Christie Laboratories, McGill University, Montreal, QC, Canada. FAU - Ralph, Ben AU - Ralph B AD - Program in Infectious Diseases and Immunology in Global Health, Centre for Translational Biology, The Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada. AD - Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada. FAU - Angers, Isabelle AU - Angers I AD - Meakins-Christie Laboratories, McGill University, Montreal, QC, Canada. AD - Program in Translational Research in Respiratory Diseases, Department of Critical Care, The Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada. FAU - Sheppard, Donald C AU - Sheppard DC AD - Program in Infectious Diseases and Immunology in Global Health, Centre for Translational Biology, The Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada. AD - Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada. AD - Department of Medicine, McGill University, Montreal, QC, Canada. FAU - Qureshi, Salman T AU - Qureshi ST AD - Division of Experimental Medicine, McGill University, Montreal, QC, Canada. AD - Meakins-Christie Laboratories, McGill University, Montreal, QC, Canada. AD - Program in Translational Research in Respiratory Diseases, Department of Critical Care, The Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada. AD - Department of Medicine, McGill University, Montreal, QC, Canada. LA - eng PT - Journal Article DEP - 20180119 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 PMC - PMC5780350 OTO - NOTNLM OT - Cryptococcus neoformans OT - cytokines OT - fungal pneumonia OT - interleukin-1 OT - interleukin-1 receptor OT - lung inflammation OT - lymphocyte differentiation OT - macrophage polarization EDAT- 2018/02/07 06:00 MHDA- 2018/02/07 06:01 PMCR- 2017/01/01 CRDT- 2018/02/07 06:00 PHST- 2017/09/25 00:00 [received] PHST- 2017/12/21 00:00 [accepted] PHST- 2018/02/07 06:00 [entrez] PHST- 2018/02/07 06:00 [pubmed] PHST- 2018/02/07 06:01 [medline] PHST- 2017/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2017.01987 [doi] PST - epublish SO - Front Immunol. 2018 Jan 19;8:1987. doi: 10.3389/fimmu.2017.01987. eCollection 2017.